News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
116 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (92)
2 (55)
3 (1)
4 (4)
5 (65)
6 (116)
7 (86)
8 (101)
9 (46)
10 (4)
11 (5)
12 (90)
13 (97)
14 (81)
15 (116)
16 (43)
17 (1)
18 (12)
19 (98)
20 (90)
21 (83)
22 (111)
23 (47)
26 (66)
27 (70)
28 (93)
29 (55)
30 (39)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
26
27
28
29
30
31
Drug Development
Bioverativ Announces First Patient Dosed in Phase 3 Study of BIVV009 for Treatment of Cold Agglutinin Disease
Significant unmet need for a treatment for cold agglutinin disease, a chronic rare blood disease that can result in life-threatening events like stroke.
March 6, 2018
·
7 min read
Drug Development
Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials
EMPERIAL clinical trials will evaluate the effect of Jardiance (empagliflozin) on exercise ability and heart failure symptoms in people with chronic heart failure; EMPERIAL is part of the most comprehensive clinical trial program of an SGLT2 inhibitor in chronic heart failure
March 6, 2018
·
12 min read
Business
HIMSS Analytics Announces Collaboration to Advance Supply Chain Capacity in Global Health Systems
Through this unique initiative HIMSS Analytics will accelerate the development and launch of evidence-based tools to support supply chain transformation in global health systems.
March 6, 2018
·
2 min read
Pharm Country
Citius Reports Progress in Hemorroid Treatment Program
Selection of higher potency corticosteroid for Phase 2b Trial to improve efficacy and faster onset of symptomatic relief.
March 6, 2018
·
4 min read
Business
Disarm Therapeutics Expands Scientific Advisory Board with Experts in Neurology, Neuropathy, and Axonal Degeneration
Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease, today announced new Scientific Advisory Board (SAB) members.
March 6, 2018
·
4 min read
Job Trends
ESO Launches Surveillance Form for Overdose
Specialty Patient Form to help standardize definitions and data collection, highlight responder safety.
March 6, 2018
·
3 min read
Job Trends
Medacta Emphasizes Flexibility for Surgeons and Patients Alike With Launch of MOTO Medial Partial Knee, Medacta Shoulder System and MasterLoc Lateralized Plus at AAOS
MOTO Knee offers unmatched configurations and flexibility for partial knee arthroplasty.
March 6, 2018
·
5 min read
BioMidwest
Materialise to Launch TRUMATCH® Personalized Solutions Shoulder System
Expanded collaboration with DePuy Synthes provides surgeons access to online planning platform and 3D printed guides for shoulder surgery.
March 6, 2018
·
5 min read
Business
Wiley Reports Third Quarter 2018 Results
Year-to-date revenue up 4% to $1,318.9 million, or up 1% at constant currency
March 6, 2018
·
23 min read
Business
National Pharmaceutical Council Welcomes Four Biopharmaceutical Companies as Members
The National Pharmaceutical Council, a health policy research organization based in Washington, DC, today welcomed four biopharmaceutical companies to its growing membership roster.
March 6, 2018
·
3 min read
Previous
3 of 12
Next